Filing Flows › RxSight (RXST) › Rxlal revenue
RxSight (RXST) Rxlal revenue by quarter
RxSight's Rxlal revenue was $22.8M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 7 quarters it ranged from $22.8M (Q3 2026) to $28.2M (Q4 2025).
| Quarter | Rxlal revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $22.8M | -7% | -11% |
| Q2 2026 | $24.5M | -9% | -9% |
| Q1 2026 | $27.0M | -4% | -0.5% |
| Q4 2025 | $28.2M | +10% | — |
| Q3 2025 | $25.7M | -5% | — |
| Q2 2025 | $27.0M | -0.7% | — |
| Q1 2025 | $27.2M | — | — |
Q3 2026 at a glance
RxSight, Q3 2026: revenue $24.6M (-19% year over year), operating margin -75.3%, net loss $16.2M, operating cash flow $45.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is RxSight's Rxlal revenue?
RxSight's Rxlal revenue was $22.8M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has RxSight's Rxlal revenue changed?
Over the last 7 quarters it ranged from $22.8M (Q3 2026) to $28.2M (Q4 2025).